AAPL 169.89 0.5147% MSFT 399.04 -2.4495% GOOG 157.95 -1.9553% GOOGL 156.0 -1.9669% AMZN 173.67 -1.6535% NVDA 826.32 3.7087% META 441.38 -10.5613% TSLA 170.18 4.9652% TSM 136.58 2.7149% LLY 724.87 -1.0011% V 275.16 0.0509% AVGO 1294.42 2.9917% JPM 193.37 0.1502% UNH 493.86 1.3462% NVO 125.79 -0.2933% WMT 60.21 0.5679% LVMUY 167.91 -2.1618% XOM 121.35 0.2478% LVMHF 837.0 -2.6461% MA 462.11 -0.0843%
Last update at 2024-04-25T20:10:00Z
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Income before tax | 26343.00M | 22310.00M | 20742.00M | 17981.00M | 15944.00M |
Minority interest | -519.00000M | -447.00000M | 366.00M | 400.00M | 396.00M |
Net income | 20120.00M | 17285.00M | 15403.00M | 13839.00M | 11986.00M |
Selling general administrative | 47782.00M | 42579.00M | 41704.00M | 35193.00M | 34074.00M |
Selling and marketing expenses | - | - | - | - | - |
Gross profit | 77587.00M | 67328.00M | 65498.00M | 55712.00M | 52470.00M |
Reconciled depreciation | 3400.00M | 3103.00M | 2891.00M | 2720.00M | 2428.00M |
Ebit | 28435.00M | 23970.00M | 22405.00M | 19685.00M | 15968.00M |
Ebitda | 29805.00M | 24749.00M | 23794.00M | 20519.00M | 18396.00M |
Depreciation and amortization | 1370.00M | 779.00M | 1389.00M | 834.00M | 2428.00M |
Non operating income net other | - | - | - | - | - |
Operating income | 28435.00M | 23970.00M | 22405.00M | 19685.00M | 17344.00M |
Other operating expenses | 295727.00M | 263627.00M | 234736.00M | 222470.00M | 208903.00M |
Interest expense | 2092.00M | 1660.00M | 1663.00M | 1704.00M | 1400.00M |
Tax provision | 5704.00M | 4578.00M | 4973.00M | 3742.00M | 3562.00M |
Interest income | 2092.00M | 1660.00M | 1663.00M | 1704.00M | 1400.00M |
Net interest income | -2092.00000M | -1660.00000M | -1663.00000M | -1704.00000M | -1400.00000M |
Extraordinary items | - | - | - | 0.00000M | 0.00000M |
Non recurring | - | - | - | - | - |
Other items | - | - | - | - | - |
Income tax expense | 5704.00M | 4578.00M | 4973.00M | 3742.00M | 3562.00M |
Total revenue | 322132.00M | 285273.00M | 255639.00M | 240269.00M | 224871.00M |
Total operating expenses | 51182.00M | 45682.00M | 44595.00M | 37913.00M | 36502.00M |
Cost of revenue | 244545.00M | 217945.00M | 190141.00M | 184557.00M | 172401.00M |
Total other income expense net | -2092.00000M | -1660.00000M | -1663.00000M | -1704.00000M | 1376.00M |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | 20639.00M | 17732.00M | 15769.00M | 14239.00M | 12382.00M |
Net income applicable to common shares | 20120.00M | 17285.00M | 15403.00M | 13839.00M | 11986.00M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Total assets | 245705.00M | 212206.00M | 197289.00M | 173889.00M | 152221.00M |
Intangible assets | 14401.00M | 10044.00M | 10856.00M | 10349.00M | 9325.00M |
Earning assets | - | - | - | - | - |
Other current assets | 23477.00M | 23635.00M | 21067.00M | 16567.00M | 12980.00M |
Total liab | 159358.00M | 135727.00M | 126750.00M | 111727.00M | 95994.00M |
Total stockholder equity | 81450.00M | 75045.00M | 68328.00M | 60436.00M | 54319.00M |
Deferred long term liab | 2769.00M | 3265.00M | 3367.00M | 2993.00M | 2474.00M |
Other current liab | 53996.00M | 47618.00M | 42887.00M | 33600.00M | 28949.00M |
Common stock | 9.00M | 10.00M | 10.00M | 9.00M | 10.00M |
Capital stock | 9.00M | 10.00M | 10.00M | 9.00M | 10.00M |
Retained earnings | 86156.00M | 77134.00M | 69295.00M | 61178.00M | 55846.00M |
Other liab | 11775.00M | 15052.00M | 15682.00M | 9982.00M | 8204.00M |
Good will | 93352.00M | 75795.00M | 71337.00M | 65659.00M | 58910.00M |
Other assets | 20714.00M | 107334.00M | 52752.00M | 13810.00M | 8346.00M |
Cash | 23365.00M | 21375.00M | 16921.00M | 10985.00M | 10866.00M |
Cash and equivalents | 27911.00M | 21375.00M | 16921.00M | 10985.00M | 10866.00M |
Total current liabilities | 89237.00M | 78292.00M | 72420.00M | 61782.00M | 53209.00M |
Current deferred revenue | 3075.00M | 2571.00M | 2842.00M | 2622.00M | 2396.00M |
Net debt | 34258.00M | 24628.00M | 26546.00M | 29693.00M | 25688.00M |
Short term debt | 3110.00M | 3620.00M | 4819.00M | 3870.00M | 1973.00M |
Short long term debt | 3110.00M | 3620.00M | 4819.00M | 3870.00M | 1973.00M |
Short long term debt total | 57623.00M | 46003.00M | 43467.00M | 40678.00M | 36554.00M |
Other stockholder equity | 3678.00M | 3285.00M | 2837.00M | 2827.00M | 2623.00M |
Property plant equipment | 10128.00M | 8969.00M | 8626.00M | 8704.00M | 8458.00M |
Total current assets | 69069.00M | 61758.00M | 53718.00M | 42634.00M | 38692.00M |
Long term investments | 43728.00M | 43114.00M | 41242.00M | 37209.00M | 32510.00M |
Net tangible assets | -25084.00000M | 75045.00M | -14491.00000M | -16666.00000M | -14631.00000M |
Short term investments | 4546.00M | 2532.00M | 2860.00M | 3260.00M | 3458.00M |
Net receivables | 17681.00M | 14216.00M | 12870.00M | 11822.00M | 11388.00M |
Long term debt | 54513.00M | 42383.00M | 38648.00M | 36808.00M | 34581.00M |
Inventory | - | - | - | - | - |
Accounts payable | 29056.00M | 24483.00M | 21872.00M | 21690.00M | 19891.00M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | 3678.00M | 3285.00M | 2837.00M | 2820.00M | 2623.00M |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | -8393.00000M | -5384.00000M | -3814.00000M | -3578.00000M | -4160.00000M |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | 9.00M | 10.00M | 10.00M | 9.00M | 10.00M |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | 86156.00M | 77134.00M | 69295.00M | 61178.00M | 55846.00M |
Treasury stock | - | - | - | - | - |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | 12258.00M | 107334.00M | 102329.00M | 94046.00M | 1852.00M |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 176636.00M | 150448.00M | 143571.00M | 131255.00M | 113529.00M |
Capital lease obligations | - | - | - | - | - |
Long term debt total | 54513.00M | 42383.00M | 38648.00M | 36808.00M | 34581.00M |
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Investments | -28476.00000M | -1843.00000M | -2836.00000M | -2504.00000M | -4099.00000M |
Change to liabilities | 6143.00M | -3553.00000M | 5778.00M | 2084.00M | 2395.00M |
Total cashflows from investing activities | -28476.00000M | -10372.00000M | -12532.00000M | -12699.00000M | -12385.00000M |
Net borrowings | 12536.00M | 2481.00M | 2586.00M | 3994.00M | 4134.00M |
Total cash from financing activities | 4226.00M | -7455.00000M | -3590.00000M | -5625.00000M | -4365.00000M |
Change to operating activities | 2679.00M | 1522.00M | 2895.00M | -342.00000M | 1081.00M |
Net income | 20639.00M | 17732.00M | 15769.00M | 14239.00M | 12382.00M |
Change in cash | 1990.00M | 4454.00M | 5936.00M | 119.00M | -1115.00000M |
Begin period cash flow | 21375.00M | 16921.00M | 10985.00M | 10866.00M | 11981.00M |
End period cash flow | 23365.00M | 21375.00M | 16921.00M | 10985.00M | 10866.00M |
Total cash from operating activities | 26206.00M | 22343.00M | 22174.00M | 18463.00M | 15713.00M |
Issuance of capital stock | 1253.00M | 1355.00M | 1440.00M | 1037.00M | 838.00M |
Depreciation | 3400.00M | 3103.00M | 2891.00M | 2720.00M | 2428.00M |
Other cashflows from investing activities | -25674.00000M | -1254.00000M | -7645.00000M | -8124.00000M | -6223.00000M |
Dividends paid | -5991.00000M | -5280.00000M | -4584.00000M | -3932.00000M | 3320.00M |
Change to inventory | - | -1031.00000M | -2195.00000M | -1563.00000M | -750.00000M |
Change to account receivables | -2523.00000M | -1000.00000M | -688.00000M | 162.00M | -1351.00000M |
Sale purchase of stock | -7000.00000M | -5000.00000M | -4250.00000M | -5500.00000M | -4500.00000M |
Other cashflows from financing activities | 18979.00M | 4620.00M | 6954.00M | 4520.00M | 5418.00M |
Change to netincome | -79.00000M | 433.00M | 619.00M | 821.00M | 609.00M |
Capital expenditures | 2802.00M | 2454.00M | 2051.00M | 2071.00M | 2063.00M |
Change receivables | -2523.00000M | 1000.00M | -688.00000M | 162.00M | -1351.00000M |
Cash flows other operating | -1374.00000M | 1031.00M | -2195.00000M | -1563.00000M | -750.00000M |
Exchange rate changes | - | -62.00000M | -116.00000M | -20.00000M | -78.00000M |
Cash and cash equivalents changes | 1956.00M | -40232.00000M | 5936.00M | 119.00M | -1115.00000M |
Change in working capital | 2246.00M | 1522.00M | 2895.00M | 683.00M | 294.00M |
Stock based compensation | 925.00M | 800.00M | 679.00M | 697.00M | 638.00M |
Other non cash items | 673.00M | -944.00000M | -52.00000M | 294.00M | 325.00M |
Free cash flow | 23404.00M | 19889.00M | 20123.00M | 16392.00M | 13650.00M |
Sector: Healthcare Industry: Healthcare Plans
Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
UNH UnitedHealth Group Incorporated |
6.56 1.35% | 493.86 | 22.57 | 18.38 | 1.33 | 5.65 | 1.38 | 13.97 |
ELV Elevance Health Inc |
5.95 1.11% | 539.68 | 18.00 | 12.66 | 0.65 | 2.87 | 0.74 | |
CVS CVS Health Corp |
-0.44 0.65% | 67.33 | 12.06 | 9.08 | 0.29 | 1.34 | 0.47 | 8.96 |
CI Cigna Corp |
2.23 0.63% | 354.51 | 16.80 | 10.45 | 0.46 | 1.90 | 0.58 | |
HUM Humana Inc |
-4.57 1.45% | 311.41 | 19.16 | 14.60 | 0.56 | 3.37 | 0.53 |
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The OptumHealth segment provides care delivery, care management, wellness and consumer engagement, and health financial services for consumers, care delivery systems, providers, employers, payers, and public-sector entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.
UnitedHealth Group Center, Minnetonka, MN, United States, 55343
Name | Title | Year Born |
---|---|---|
Sir Andrew Philip Witty | CEO & Director | 1965 |
Mr. Dirk C. McMahon | Pres & COO | 1960 |
Mr. John F. Rex | Exec. VP & CFO | 1962 |
Mr. Brian Robert Thompson | Exec. VP & CEO of UnitedHealthcare | NA |
Mr. Thomas Edward Roos | Sr. VP & Chief Accounting Officer | 1973 |
Mr. Sandeep Dadlani | Exec. VP and Chief Digital & Technology Officer | 1975 |
Mr. Zachary William Sopcak | Sr. VP of Capital Markets Communications & Investor Relations | NA |
Mr. Rupert Bondy | Exec. VP & Chief Legal Officer | 1962 |
Ms. Jennifer Mound Smoter | Sr. VP & Chief Communications Officer | NA |
Mr. James T. Barry Jr. | Director of Sales for Western Pennsylvania | 1946 |
Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).